Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.560
-0.100 (-2.73%)
At close: Mar 6, 2026, 4:00 PM EST
3.600
+0.040 (1.12%)
After-hours: Mar 6, 2026, 4:48 PM EST
Cellectis Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cellectis stock have an average target of 8.50, with a low estimate of 8.00 and a high estimate of 9.00. The average target predicts an increase of 138.76% from the current stock price of 3.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 23, 2025.
Analyst Ratings
The average analyst rating for Cellectis stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +152.81% | Dec 23, 2025 |
| Barclays | Barclays | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +124.72% | Oct 17, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +12.36% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +40.45% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +180.90% | Jun 12, 2024 |
Financial Forecast
Revenue This Year
69.09M
from 49.22M
Increased by 40.37%
Revenue Next Year
63.75M
from 69.09M
Decreased by -7.73%
EPS This Year
-0.94
from -0.41
EPS Next Year
-1.18
from -0.94
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 87.0M | 92.7M | ||||
| Avg | 69.1M | 63.7M | ||||
| Low | 39.2M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 76.9% | 34.1% | ||||
| Avg | 40.4% | -7.7% | ||||
| Low | -20.4% | -57.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.66 | -0.90 | |
| Avg | -0.94 | -1.18 | |
| Low | -1.46 | -1.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.